Literature DB >> 114532

Rapid serogroup identification of Neisseria meningitidis by using antiserum agar: Prevalence of serotypes in a disease-free military population.

D E Craven, C E Frasch, L F Mocca, F B Rose, R Gonzalez.   

Abstract

Nasopharyngeal cultures from 414 Marines were plated directly onto antiserum agar containing the antibiotics vancomycin, colistin, and nystatin for meningococcal isolation and serogroup identification. Meningococci were isolated from 267 Marines, giving a carrier prevalence of 64.5%. A total of 58% of the isolates could be placed into serogroups; of these 22.3% were group B, 4.7% were group C, 25.7% were group Y, 24.3% were group W135, and 23.0% were group 29E. No serogroup A organisms were recovered. Serotyping by agar gel double diffusion was performed on 148 strains. More than 70% of these strains were nontypable, and the disease-associated serotype 2 was present only in two group Y isolates. The same 148 isolates were also classified by major outer membrane protein patterns after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Polyacrylamide gel electrophoresis pattern IV was most common among all serogroups. The data demonstrate the effective use of antiserum agar for meningococcal surveillance and document the frequency of specific serotypes and polyacrylamide gel electrophoresis types among carrier isolates obtained from a nonrecruit military population.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 114532      PMCID: PMC273157          DOI: 10.1128/jcm.10.3.302-307.1979

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Use of antiserum agar plates for serogrouping of meningococci.

Authors:  A Sivonen; O V Renkonen; J B Robbins
Journal:  J Clin Pathol       Date:  1977-09       Impact factor: 3.411

2.  Meningococcal disease in Alabama.

Authors:  J A Jacobson; C E Frasch
Journal:  J Infect Dis       Date:  1978-03       Impact factor: 5.226

3.  Serogroup identification of Neisseria meningitidis: comparison of an antiserum agar method with bacterial slide agglutination.

Authors:  D E Craven; C E Frasch; J B Robbins; H A Feldman
Journal:  J Clin Microbiol       Date:  1978-05       Impact factor: 5.948

4.  Epidemiologic studies of serotype antigens common to groups B and C Neisseria meningitidis.

Authors:  R S Munford; C M Patton; G W Gorman
Journal:  J Infect Dis       Date:  1975-03       Impact factor: 5.226

5.  Differences between sexes in the nasopharyngeal carriage of Neisseria meningitidis.

Authors:  L J Melton; E A Edwards; L F Devine
Journal:  Am J Epidemiol       Date:  1977-09       Impact factor: 4.897

6.  Immunoepidemiology of meningococcal disease in military recruits. I. A model for serogroup independency of epidemic potential as determined by serotyping.

Authors:  J M Griffiss; D D Broud; C A Silver; M S Artenstein
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

7.  An epidemic of disease due to serogroup B Neisseria meningitidis in Alabama: report of an investigation and community-wide prophylaxis with a sulfonamide.

Authors:  J A Jacobson; T J Chester; D W Fraser
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

8.  Lipopolysaccharide serotyping of Neisseria meningitidis by hemagglutination inhibition.

Authors:  R E Mandrell; W D Zollinger
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

9.  Role of protein serotype antigens in protection against disease due to Neisseria meningitidis.

Authors:  C E Frasch
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

10.  Outer-membrane protein and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid-phase radioimmunoassay.

Authors:  W D Zollinger; R E Mandrell
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

View more
  19 in total

Review 1.  The meningococcus and mechanisms of pathogenicity.

Authors:  I W DeVoe
Journal:  Microbiol Rev       Date:  1982-06

2.  Natural bactericidal activity of human serum against Neisseria meningitidis isolates of different serogroups and serotypes.

Authors:  D E Craven; K T Shen; C E Frasch
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

3.  Metabolic analysis of serologically defined Neisseria meningitidis isolates by frequency-pulsed electron capture gas-liquid chromatography.

Authors:  J B Brooks; D S Kellogg; M E Shepherd; D E Craven
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

4.  Acute urethritis due to Neisseria meningitidis group A acquired by orogenital contact: case report.

Authors:  A P Wilson; J Wolff; W Atia
Journal:  Genitourin Med       Date:  1989-04

Review 5.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

6.  Appearance of new strains associated with group B meningococcal disease and their use for rapid vaccine development.

Authors:  C E Frasch; L F Mocca; A B Karpas
Journal:  Antonie Van Leeuwenhoek       Date:  1987       Impact factor: 2.271

7.  Sodium dodecyl sulfate-polyacrylamide gel typing system for characterization of Neisseria meningitidis isolates.

Authors:  L F Mocca; C E Frasch
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

8.  Identity between polysaccharide antigens of Moraxella nonliquefaciens, group B Neisseria meningitidis, and Escherichia coli K1 (non-O acetylated).

Authors:  S J Devi; R Schneerson; W Egan; W F Vann; J B Robbins; J Shiloach
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

9.  Carriage of Neisseria meningitidis and Neisseria lactamica in a school population during an epidemic period in Spain.

Authors:  J A Saez-Nieto; J R Dominguez; J L Monton; P Cristobal; A Fenoll; J Vazquez; J Casal; B Taracena
Journal:  J Hyg (Lond)       Date:  1985-06

10.  Meningococcal phenotypic and genotypic characteristics and human antibody levels.

Authors:  B E Kristiansen; K W Lind; K Mevold; B Sørensen; L O Frøholm; K Bryn; T Tjade; K Bøvre
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.